Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2022 – By Type (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development And Manufacturing, Secondary Packaging), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End-User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : February 2022 | SKU CODE : 7639 | Delivery Time: 2-3 business days | Format :


The pharmaceutical contract development and manufacturing market consists of sales of pharmaceutical contract development and manufacturing products and related services. Some pharmaceutical companies outsource the manufacturing of products on contracts to focus on the R&D, marketing and branding of their products. The pharmaceutical contract development and manufacturing market consists of manufacturing firms who manufacture drugs and other pharmaceutical products for other pharmaceutical companies on contractual basis.

The main types of pharmaceutical contract development and manufacturing organization (CMO) are active pharmaceutical ingredient (API) manufacturing, finished dosage formulation (FDF) development and manufacturing, secondary packaging. The active pharmaceutical ingredient (API) manufacturing includes the manufacturing of the part of any drug that produces the desired effects. The various research phases include preclinical, phase I, phase II, phase III, phase IV. The different end use sectors include big pharmaceutical companies, generic pharmaceutical companies, small & medium-sized pharmaceutical companies.

The global pharmaceutical contract development and manufacturing organization (CMO) market size is expected to grow from $114.36 billion in 2021 to $122.31 billion in 2022 at a compound annual growth rate (CAGR) of 7%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pharmaceutical CMO market is expected to reach $159.94 billion in 2026 at a CAGR of 6.9%.

The growth of the pharmaceutical contract development and manufacturing market is driven by the increase in the demand for medicines across the globe. The high prevalence of diseases and the need for a longer lifespan increased the demand for medicines pushing the pharmaceutical companies to increase the production of existing drugs and raise the investment in their R&D to promote the development of new drugs. This impels the pharmaceutical companies to collaborate with contract manufacturing organizations (CMOs) as a way to lower operational costs, thus, increasing the demand in pharmaceutical contract development and manufacturing market. According to Alkermes plc, a biopharmaceutical company indicates that pharmaceutical contract manufacturing will emerge as a strategic option for many companies ranging from very large to smaller specialty pharma entities and this mostly will happen because the pharmaceuticals companies are looking for cost cutting.

The pharmaceutical contract development and manufacturing market is restricted by the poor-capacity utilization of manufacturing facilities. The capacity utilization is calculated considering the full potential capacity of the production plant. The poor-capacity utilization of the production plant is caused due to the inefficiency of different sub-processes in the production line which results in low production. The low production output results in low revenue generation for the production unit, affecting the overall pharmaceutical contract development and manufacturing market. For instance, according to a 2019 article by the Trade Promotion Council of India (TPCI) most of the pharmaceutical production units in India run at 30-40% of their capacity. Therefore, the under usage of capacity of production plant negatively affects the pharmaceutical contract development and manufacturing market.

The companies in the pharmaceutical contract development and manufacturing market are investing towards acquiring and forming alliances with other companies in the market. The pharmaceutical contract development and manufacturing companies are following the trend of merger and acquisition in order to expand their global market reach to meet the client needs, to increase their production capabilities while maintaining cost efficiencies and to get access to latest technology and new services. The high levels of merger and acquisition activities are resulting in consolidation of the contract service providers. For instance, according to a PricewaterhouseCoopers report, the largest M&A activity in the contract development and manufacturing organization sector was the deal between Thermo Fisher Scientific and Patheon, where the former acquired the latter for $7.2 billion. Also other important acquisitions were Thermo Fisher’s acquisition of Brammer Bio for $1.7 billion in 2019 and PAG’s acquisition of Acme Formulation Pvt Ltd., in 2021 for $145 million.

In 2019, Permira Funds, a European equity firm acquired Cambrex Corporation for $2.4 billion. The acquisition is aimed to strengthen and expand the products and services offered by Cambrex Corporation towards the manufacturing of drugs. The Cambrex Corporation is a USA based contract development and manufacturing (CDMO) firm involved with the products and services related to small molecule active pharmaceutical ingredients.

Major players in the pharmaceutical contract development and manufacturing market are Recipharm AB, Pfizer Inc., Boehringer Ingelheim International GmbH., Aenova Group, Famar, Jubilant Life Sciences Limited, Catalent Pharma Solutions, Chemicals Limited, Dishman Pharmaceuticals, HAUPT Pharma AG, Kemwell Pvt. Ltd., Nipro Corp., NextPharma, Royal DSM N.V, Althea Technologies, Thermo Fisher Scientific Inc., Lonza Group Ltd, AbbVie Inc., Consort Medical plc, Almac Group, Siegfried Holding AG, Evonik Industries AG and Vetter Pharma International GMBH.

North America was the largest region in the pharmaceutical contract development and manufacturing market in 2021. The Middle East is expected to be the fargest growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (CMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical contract development and manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK USA.

The global pharmaceutical contract development and manufacturing organization market is segmented -

1) By Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging

2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV

3) By End-User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small and Medium-Sized Pharmaceutical Companies

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Characteristics

    3. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Trends And Strategies

    4. Impact Of COVID-19 On Pharmaceutical Contract Development And Manufacturing Organization (CMO)

    5. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Size And Growth

    5.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Segmentation

    6.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Active Pharmaceutical Ingredient (API) Manufacturing

    Finished Dosage Formulation (FDF) Development And Manufacturing

    Secondary Packaging

    6.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Preclinical

    Phase I

    Phase II

    Phase III

    Phase IV

    6.3. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Big Pharmaceutical Companies

    Generic Pharmaceutical Companies

    Small & Medium-Sized Pharmaceutical Companies

    7. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Regional And Country Analysis

    7.1. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    8.1. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    9.1. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    9.2. China Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    10.1. India Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    11.1. Japan Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    12.1. Australia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    13.1. Indonesia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    14.1. South Korea Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    15.1. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    15.2. Western Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    16.1. UK Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    17.1. Germany Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    18.3. France Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    19.1. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    19.2. Eastern Europe Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    20.1. Russia Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    21.1. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    21.2. North America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    22.1. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    22.2. USA Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    23.1. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    23.2. South America Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    24.1. Brazil Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    25.1. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    25.2. Middle East Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    26.1. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Overview

    26.2. Africa Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape And Company Profiles

    27.1. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Competitive Landscape

    27.2. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Company Profiles

    27.2.1. Recipharm AB

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Pfizer Inc.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Catalent Pharma Solutions

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Aenova Group

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Famar

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Key Mergers And Acquisitions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market

    29. Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: Recipharm AB Financial Performance
  • Table 28: Pfizer Inc. Financial Performance
  • Table 29: Catalent Pharma Solutions Financial Performance
  • Table 30: Aenova Group Financial Performance
  • Table 31: Famar Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Research Phase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: Recipharm AB Financial Performance
  • Figure 28: Pfizer Inc. Financial Performance
  • Figure 29: Catalent Pharma Solutions Financial Performance
  • Figure 30: Aenova Group Financial Performance
  • Figure 31: Famar Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Pharmaceutical Packaging Equipment Global Market Report 2022 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterialization Equipment), By Packaging Type (Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment), By Equipment Type (Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines), By Mode of Administration (Injectable Administration, Topical Administration, Oral Administration) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Contract Research Organizations Market - By Service Type (Drug Discovery, Preclinical Studies), By Therapeutic Area (Oncology, Infectious Diseases, Cardiovascular Diseases, Metabolic Disease), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Pharmaceutical API Manufacturing Global Market Report 2022 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Nsaids, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Pharmaceutical Drugs Global Market Report 2022 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorders Drugs, Musculoskeletal Disorders Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Administration (Oral, Parenteral), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Pharmaceutical Excipients Global Market Report 2022 – By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavouring Agents And Sweetners, Disintegrants, Colorants, Lubricants And Glidants), By Type Of Formulation (Oral Fromulation, Topical Formulation, Parental Formulation), By Product (Inorganic Chemicals, Organic Chemicals) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Pharmaceutical Sterility Testing Global Market Report 2022 – By Sample (Sterile Drugs, Medical Devices, Biologics And Therapeutics), By Product Type (Instruments, Kits And Reagents, Services), By Type (In- House, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Contract Development Manufacturing Organizations Global Market Report 2022 – By Service (CMO, CRO), By Product (Small Molecules, Biologics), By End User (Big Pharma, Small and Mid-size Pharma, Generic Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Pharmaceutical Drugs And Biologics Logistics Market 2021 - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)